Delivery Order SPE2DB22D3301-SPE2DB24FY9LE

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $4,776.57 delivery order for the supply of "LIDOCAINE 5% PATCH 30S" to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a delivery order valued at $9,724.64. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to supply 4564085149 LIDOCAINE 5% PATCH 30S. The contract does not have a set-aside designation and is a firm fixed price delivery order with an ultimate completion date of March 27,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,366.03 firm fixed price delivery order was awarded on July 11, 2024 with a completion date of July 12, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $5,372.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564702356 - LIDOCAINE 5% PATCH 30S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of May 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,733.31 for the supply of 4560649611 - LIDOCAINE 5% PATCH 30S. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 20, 2023. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $1,026.81 for the supply of 4563927893 - LIDOCAINE 5% PATCH 30S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this firm fixed price contract, which is not designated...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,893.84 firm fixed-price delivery order is for the supply of 4563756347 - LIDOCAINE 5% PATCH 30S, with a completion date of February 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,125.90 firm-fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of July 5, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,365.72 firm fixed-price delivery order is for the supply of 4,564,298,909 LIDOCAINE 5% PATCH 30S, with an ultimate completion date of April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
This federal contract award is for a delivery order with a ceiling value of $3,188.69 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract covers the procurement of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a period of performance through December 17, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9LE
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $9,102.72 for the supply of LIDOCAINE 5% PATCH 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has an ultimate completion date of June 28, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific Delivery Order contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen's expertise in pharmaceutical distribution and its existing IDCs with key federal agencies position the company as a competitive supplier of critical medical commodities to the U.S. government.

Generated 9/26/24, 9:29 AM